Skip to main content
. 2019 Dec 16;13:553. doi: 10.3389/fncel.2019.00553

FIGURE 10.

FIGURE 10

Meisoindigo treatment inhibits NLRP3 inflammasome activation through down-regulation of TLR4 pathways after OGD/R in HT-22. (A) Representative Western blot membranes for TLR4, NF-κB p65, phosphorylated NF-κB p65, NLRP3, ASC, CL-caspase-1, and IL-1β. Quantitative analysis of TLR4 (B), NF-κB p65 (C), phosphorylated NF-κB p65 (D), NLRP3 (E), ASC (F), CL-caspase-1 (G), and IL-1β (H) proteins expression levels. Mean ± SD; n = 3/group. aP < 0.05 vs. sham; bP < 0.05 vs. vehicle + OGD/R; cP < 0.05 vs. LPS + OGD/R.